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F90	 for	all	participants;	B	 (n=5):	Feeding	 trial	 limb	showing	Trial	 F90	 (90’	Feed),	Trial	F30	 (30’	
Feed)	and	Trial	F4:1	(4:1	K:C	Feed)	with	main	effect	of	treatment	(P<0.01),	time	(P<0.001)	and	
treatment	x	time	(P<0.001);	C	(n=5):	Exercise	trial	limb	showing	Trial	F90	(90’	Feed),	Trial	E15	(15’	








taken	 to	 complete	 the	 first	 main	 trial	 (Trial	 A;	 n=12	 male	 cyclists).	 Closed	 symbols	 represent	





























































finish	 throughout	 this	 process.	 His	 unwavering	 belief	 in	me	 has	 been	 a	 constant	
source	of	motivation	and	the	fuel	that	kept	me	going	to	the	end.	
	




































(F30)	compared	to	90-minutes	 (F90))	 resulted	 in	a	 lowering	of	 the	area	under	the	
curve	for	ketone	body	concentration	in	the	90-minutes	post	dose	(AUC-BHB(0-90),	
F90	v	F30:	260.7	±	33.6	mmol/l˚min	v	201.9	±	33.4	mmol/l˚min;	P<0.05)	and	that	
reducing	 the	carbohydrate	content	of	 the	ketone	ester	drink	 (F4:1)	 resulted	 in	an	





















from	 trialling	 due	 to	 a	 perceived	 lack	 of	 efficacy)	 and	 equivocal	 effects	 on	
performance.	
This	work	provides	novel	insight	into	the	metabolic	effects	of	nutritional	ketosis	in	
highly	 trained	 athletes	 whilst	 also	 highlighting	 the	 importance	 of	 taking	 a	 wider	
psycho-physiological	 perspective	 when	 translating	 experimental	 findings	 into	
application	for	real	world	sports	performance.	When	considering	the	potential	utility	
of	 ketone	 ester	 consumption	 during	 exercise	 there	 may	 be	 a	 narrow	 window	





















and	 local	 tissue	O2	 kinetics	 and	 fuel	 availability,	 that	may	 be	 brought	 to	 bear	 on	
exercise	performance	in	a	context	dependent	manner	(Tucker	&	Noakes,	2009).	The	
recognition	that	physiological	systems	mount	an	integrative	response	to	exercise	has	
also	 led	 to	 increasing	 attention	 being	 paid	 to	 the	 anticipatory	 regulation	 of	
performance	 through	 afferent	 feedback	 (Atkinson,	 Peacock,	 St	 Clair	 Gibson,	 &	






limits	 of	 exercise	 performance	 has	 led	 to	many	 and	 varied	 attempts	 to	 influence	
exercise	 performance	 by	 physiological	 means.	 Efforts	 to	 nutritionally	 impact	 the	




The	 regulation	 of	 mitochondrial	 substrate	 has	 been	 the	 subject	 of	 intense	
speculation	ever	since	the	concept	of	a	glucose	fatty-acid	cycle	was	first	introduced	
by	 Sir	 Phillip	 Randle	 and	 colleagues	 in	 1963	 (P.J.	 Randle,	 Garland,	 Hales,	 &	
Newsholme,	1963).	In	its	original	form	the	glucose	fatty-acid	cycle	proposed	that	the	
beta	oxidation	of	circulating	free	fatty	acids	exerts	an	inhibitory	influence	on	glucose	
oxidation	 via	 the	 combined	 effects	 of	 inhibition	 of	 phosphofructokinase	 (PFK)	 by	
accumulating	 citrate	 and	 inhibition	 of	 pyruvate	 dehydrogenase	 (PDH)	 by	
accumulating	AcetylCoA.	This	model	has	since	been	reaffirmed	 in	an	updated	and	
revised	form	to	include	various	aspects	of	enzymatic	and	cell	signalling	control,	which	
were	not	known	at	 that	 time	(Philip	 J.	Randle,	1998).	Despite	 this,	 the	 role	of	 the	
glucose	 fatty-acid	cycle	as	a	mainstay	 in	 the	 regulation	of	 substrate	switching	has	
been	challenged,	particularly	in	relation	to	the	insulin	resistance	of	diabetes	(Kelley	










carbohydrate	 as	 energetic	 demand	 increases	 and	 oxygen	 abundance	 diminishes,	
reflecting	 the	 need	 for	 an	 improved	 P/O	 ratio	 (Fontaine	&	 Leverve,	 2001).	 In	 the	




peaking	 at	 around	 65%	 VO2max,	 whilst	 the	 role	 of	 carbohydrate	 increases	
continuously	as	exercise	intensity	goes	up	and	the	rate	of	demand	for	high	energy	
phosphates	increases.	There	is	now	growing	evidence	to	support	a	predominant	role	
for	 both	 local	 contractile	 mechanics	 and	 local	 tissue	 energetics	 in	 the	 signalling	
cascade	 that	 promotes	 an	 increase	 in	 exercising	 mitochondrial	 carbohydrate	
oxidation	(Rose	&	Richter,	2005).	Further	to	this,	it	would	appear	that	this	increased	
glycolytic	flux	exerts	an	inhibitory	effect	on	beta	oxidation	through	its	influence	on	














with	a	concomitant	 impact	on	endurance	performance	 in	exercising	 rats	(Hickson,	
Rennie,	 Conlee,	 Winder,	 &	 Holloszy,	 1977)	 although	 this	 finding	 has	 not	 been	
consistently	 replicated	 in	 humans	 (Hargreaves	 et	 al.,	 2004).	 Endurance	 exercise	
training	 itself	 confers	 a	 degree	 of	 glycogen	 sparing	 by	 increasing	 reliance	 upon	









suggesting	 that	 carbohydrate	 feeding	 does	 not	 significantly	 alter	 mitochondrial	
substrate	selection	during	exercise.	By	contrast,	acute	high	fat	feeding	can	increase	


















The	observation	 that	 fat	oxidation	 carries	 an	additional	oxygen	 cost,	which	 is	not	




currently	 understood	 about	 the	 dynamics	 of	 mitochondrial	 uncoupling	 during	
exercise,	 although	 it	 is	 known	 that	 exercise	 training	 promotes	 a	 reduction	 in	
uncoupling	protein	3	(UCP3)	levels	in	muscle	mitochondria	(Fernström,	Tonkonogi,	&	






remains	 largely	 unexplored.	 Exercise	 training	has	been	 shown	 to	hasten	 the	 time	
course	of	engagement	of	mitochondrial	respiration,	as	evidenced	by	more	rapid	on-
kinetics	 for	 pulmonary	 VO2	 (S	 J	 Bailey,	 Vanhatalo,	Wilkerson,	 Dimenna,	 &	 Jones,	
2009).	However,	the	influence	of	substrate	selection	on	VO2	kinetics	requires	some	




glycolytic	 inertia	 there	 is	 only	 limited	 evidence	 of	 a	 concurrent	 reliance	 upon	 fat	
oxidation	in	the	early	exercise	transition	(Molé	&	Hoffmann,	1999).	Furthermore,	it	
has	also	been	shown	that	PDH	activation	by	DCA	causes	an	apparent	slowing	of	phase	
two	 VO2	 kinetics	 that	 appears	 contradictory	 to	 the	 effects	 of	 exercise	 training	









establish	 lactate	 as	 a	 dynamically	 regulated	 substrate	 that	 responds	 to	 energetic	




high	 demand	 (Brooks,	 2009;	 Emhoff	 et	 al.,	 2013).	 Recent	 estimates	 suggest	 that	




The	 dynamic	 interplay	 between	 lactate	 and	 pyruvate,	 regulated	 by	 lactate	
dehydrogenase,	 plays	 an	 important	 role	 in	 regulating	 cellular	 redox	 state	 (G.	 A.	
Brooks,	Dubouchaud,	Brown,	Sicurello,	&	Butz,	1999).	The	removal	of	lactate	from	
sites	of	accumulation	such	as	active	type	II	muscle	fibres	serves	both	to	stabilise	the	





rates	 of	 lactate	 flux	 serves	 to	 ensure	 that	 a	 rapidly	 combustible	 energy	 source	 is	


















cardiac	 muscle,	 with	 this	 alteration	 in	 substrate	 selection	 conferring	 energetic	
benefits	 in	 the	 form	of	an	 increased	hydraulic	efficiency	 for	 the	working	rat	heart	





preferred	 fuel	 source	both	 for	cerebral	energetics	and	 for	high	 intensity	muscular	
work.	 In	 states	 of	 severe	 or	 prolonged	 energetic	 restriction	 however,	 declining	
carbohydrate	reserves	provoke	an	increase	in	hepatic	production	of	ketone	bodies	













it	 has	 long	been	 known	 that	 ketone	body	production	 is	 readily	 inducible	 through	
dietary	 carbohydrate	 restriction	 (Koeslag,	 1982)	 in	 the	 absence	 of	 overall	 energy	
deficit.	Whilst	uncommon	in	the	post-agricultural	modern	day	diet,	it	appears	likely	
that	 for	 much	 of	 the	 evolutionary	 history	 of	 modern	 man,	 periods	 of	 enforced	
energetic	restriction	due	to	a	lack	of	food	availability	were	interspersed	with	plentiful	
food	supply,	but	with	seasonal	variation	 in	 food	sources	 that	 likely	varied	 in	 their	
carbohydrate	 content	 such	 that	 prolonged	 periods	 could	 be	 spent	 achieving	
sustenance	from	high	fat	and	protein	sources,	such	as	meat	and	fish	(Cordain,	2002).	
This	 evolutionary	 backdrop	 indicates	 that	 ketotic	 states	may	 have	 been	 far	more	
common	for	historical	man	than	they	are	today.	
	
Although	 severe	 carbohydrate	 restriction	 is	 required	 to	 induce	 ketosis	 at	 rest,	
presumably	 serving	 to	maintain	 adequate	 substrate	 supply	 to	 the	 brain,	 it	would	
appear	 that	 the	 heightened	 energetic	 demands	 of	 exercise	 are	 capable	 of	
augmenting	this	response	(Koeslag,	Noakes,	&	Sloan,	1980).	Given	the	benefits	of	a	











their	 potential	 therapeutic	 use.	 	 A	 diet	 inducing	 mild	 ketosis,	 via	 carbohydrate	
restriction	 (ketogenic	 diet),	 has	 been	 reported	 to	 improve	 movement	 disorder,	
within	days,	in	patients	with	Parkinson’s	disease	(Jabre	&	Bejjani,	2006)	and	to	reduce	
the	frequency	of	seizures	in	patients	with	epilepsy	(Kossoff,	2004).	A	ketogenic	diet	
has	 also	 shown	 therapeutic	 benefit	 in	 diabetes,	 both	 in	 rodents	 (Poplawski	 et	 al.,	
2011)	and	humans	(Yancy	et	al.,	2005).	However,	a	major	issue	with	ketogenic	diets	
is	 that	 strict	 carbohydrate	 restriction	 (<20	 g/day)	 must	 be	 enforced	 to	 raise	
circulating	ketone	body	concentration.	The	high	fat	and	low	carbohydrate	content	
make	the	diet	unpleasant,	with	the	result	that	ketogenic	diets	are	poorly	tolerated	





Given	 the	 difficulties	 associated	with	 ketogenic	 diets	 a	 number	 of	 attempts	 have	







agent	 and	 indicated	 potential	 for	 therapeutic	 gain	 (Dymsza,	 1975).	 However,	
difficulty	in	achieving	sufficient	dose	for	sustainable	ketosis	coupled	with	potential	
side	 effects	 with	 high	 level	 dosing,	 particularly	 with	 regard	 to	 alcohol	 induced	
depression	 of	 CNS	 activity	 (Frye	 et	 al.,	 1981),	 led	 to	 dwindling	 interest	 in	 this	
approach.	
	
The	 ketogenic	 potential	 of	 medium	 chain	 triglycerides	 has	 been	 examined	 with	
reports	suggesting	that	tolerable	levels	of	dietary	MCTs	are	capable	of	inducing	a	mild	


















Recent	 attempts	 to	 induce	 nutritional	 ketosis	 have	 centred	 on	 the	 use	 of	
esterification	as	a	delivery	vehicle	(Desrochers	et	al.,	1995).	A	ketone	ester	formed	
of	 acetoacetate	 and	 the	 ketogenic	 precursor	 butanediol	 (R,S-butanediol	
diacetoacetate)	has	been	shown	to	 incur	rapid	hydrolysis	by	tissue	and	circulating	
esterases	liberating	R,S-butanediol	and	acetoacetate	into	circulation.	R,S-butanediol	
undergoes	 hepatic	 clearance	 via	 oxidation	 to	 R,S-beta-hydroxybutyrate	 and	





metabolism	and	 resulted	 in	 reductions	 in	 voluntary	 food	 intake	(Kashiwaya	et	 al.,	



















Acute	dietary	 supplementation	with	a	 ketone	ester	drink	 is	 capable	of	 inducing	a	
sustained	 ketosis	 that	 has	wide	 ranging	 effects	 on	 substrate	 selection,	 exercising	
















or	 intermittent,	 for	 all	 but	 the	 shortest	 and	 most	 explosive	 sports	 there	 is	
performance	 benefit	 to	 be	 gained	 from	 some	 level	 of	 regulation	 of	 resource	
expenditure	over	attempts	 to	work	maximally	 from	task	onset	 to	 task	completion	
(Abbiss	 &	 Laursen,	 2008).	When	 pacing	 is	 ineffective	 a	 catastrophic	 loss	 of	 work	







the	 task	 and	 an	 effective	 gauge	 of	 ongoing	 resource	 expenditure	 (Tucker,	 2009).	
However,	given	that	exercise	is	almost	always	curtailed	before	actual	harm	ensues	a	
further	key	 ingredient	 in	pacing	strategy	 is	motivation	 to	 task.	Exemplifying	 this	a	
number	of	studies	have	demonstrated	that	subversive	manipulation	of	the	perceived	
balance	of	 task	demands	and	resource	availability	can	alter	actual	work	output	to	
impact	 overall	 performance	 either	 when	 demands	 are	 underestimated	 (false	
feedback;	Ansley	et	al.	2004)	or	resources	are	overestimated	(carbohydrate	mouth	
rinse;	Carter	et	al.	2004).	
For	 sustained	 endurance	 tasks	 a	 number	 of	 studies	 in	 a	 variety	 of	 contexts	 have	
















and	 improvements	 in	 mitochondrial	 lactate	 handling	 via	 the	 up	 regulation	 of	





The	 ecological	 validity	 of	 utilising	 laboratory	 trial	 data	 to	 evidence	 the	 ergogenic	
potential	of	performance	interventions	for	translation	onto	the	sports	field	has	come	
under	increasing	scrutiny	given	the	growing	mass	of	trial	data	that	now	influences	







theory	 (Phillips,	 Davids,	 Renshaw,	 &	 Portus,	 2010)	 each	 performance	 ecology	 is	
constrained	 by	 the	 shifting	 dynamics	 of	 the	 performer,	 the	 task	 at	 hand	 and	 the	




The	 training	 status	 of	 trial	 participants	 is	 an	 often	 overlooked	 constraint	 on	 the	
ergogenic	potential	of	nutritional	 interventions	 for	sports	performance.	By	way	of	
example	the	utility	of	dietary	nitrate,	most	commonly	through	the	consumption	of	
beetroot	 juice	was	well	 established	 as	 having	 ergogenic	 potential	 in	 untrained	or	
moderately	 trained	 populations	 (Stephen	 J	 Bailey	 et	 al.,	 2009;	 Lansley,	Winyard,	
Bailey,	et	al.,	2011;	Lansley,	Winyard,	Fulford,	et	al.,	2011),	and	 in	common	usage	
amongst	competitive	athletes	(Lundberg,	Larsen,	&	Weitzberg,	2011)	for	some	time	
before	 evidence	 started	 to	 emerge	 suggesting	 that	 a	 highly	 trained	 athletic	
population	may	not	benefit	from	such	intervention	(Bescós	et	al.,	2012;	Christensen,	
Nyberg,	&	Bangsbo,	 2013;	 Peacock	 et	 al.,	 2012),	most	 likely	 as	 a	 result	 of	 having	















(Pensgaard	&	Roberts,	 2000)	 and	 are	 likely	 to	 adapt	 differently	 to	 a	motivational	
climate	 that	 emphasises	 one	 or	 other	 rather	 than	 both	 of	 these	 orientations.	 If	
laboratory	 work	 is	 to	 translate	 to	 a	 high	 performance	 sporting	 context	 it	 would	
appear	desirable	that	the	motivational	climate	should	present	a	 level	of	challenge	






elegant	 guide.	 Hormonal	 signalling	 through	 the	 hypothalamic-pituitary-adrenal	
(HPA)	axis	has	been	shown	to	exert	a	modulatory	influence	over	both	functional	and	
adaptive	 responses	 to	 exercise	 stimuli	 (Crewther,	 Cook,	 Cardinale,	Weatherby,	 &	
Lowe,	2011).	Whilst	the	majority	of	work	in	this	area	has	focussed	on	the	influence	
of	HPA	axis	activity	on	strength	and	power	adaptation	to	exercise	training	(Hakkinen	
&	 Pakarinen,	 1995;	 Kraemer	 &	 Ratamess,	 2005),	 a	 growing	 body	 of	 evidence	 is	
converging	 on	 a	 critical	 role	 for	 the	 interplay	 of	 androgen	 and	 glucocorticoid	





































Experimental	 beverages	 containing	D-ß-hydroxybutyrate-R-1,3-butanediol,	 a	novel	
ketone	monoester	 (dG:	 T∆S,	Oxford,	UK),	were	developed	 in	 collaboration	with	 a	




Yellow;	Naturex,	 Swadlincote,	UK),	 and	 flavourings	 (Orange	 flavouring	 (650961)	&	
Pineapple	flavouring	(651757);	Symrise,	Marlow,	UK).	Non-ketone	ester	containing	
control	beverages	were	prepared	following	similar	procedures	with	the	addition	of	
bitter	 agents	 to	 match	 the	 flavour	 of	 the	 ketone	 ester	 beverage	 and	 with	 the	
provision	of	additional	 carbohydrate	 to	achieve	 isocaloric	matching.	All	beverages	
proceeded	 through	 a	 product	 development	 lifecycle	 involving	 prototype	












batches	 of	 end-product	 were	 subjected	 to	 a	 series	 of	 assessments.	 At	 regular	
intervals	 over	 a	 32-week	 period	 beverages	 stored	 in	 both	 refrigerated	 (8°C)	 and	
ambient	(20°C)	conditions	underwent	microbial	screening	and	nutritional,	physical	
and	 sensory	 analysis	 as	 well	 as	 being	 screened	 by	 gas	 chromatography	 mass	
spectrometry	 (GC-MS)	 for	 stability	 of	 the	 ketone	 ester.	 All	 beverages	 tested	
demonstrated	microbial	stability	and	were	safe	for	consumption	following	storage	in	
both	 conditions	 across	 the	 study	period	 and	 there	was	no	evidence	of	 significant	
ketone	ester	degradation.	Beverages	stored	in	the	ambient	condition	were	observed	
to	change	 in	colour	and	odour	over	 time	and	 therefore	all	beverages	used	 in	 this	





USA)	 certified	 as	 ‘Generally	 Recognised	 as	 Safe’	 (GRAS).	 This	 GRAS	 certification	
permits	human	consumption	of	the	ketone	ester	as	a	foodstuff	within	the	context	of	
continuing	 research	 into	 its	 efficacy	 but	 does	 not	 permit	 general	 consumption	 or	
commercial	sale.	Given	the	novel	nature	of	the	ketone	ester	UK	Sport,	as	the	research	
sponsor,	obtained	clarification	via	the	UK	Anti-Doping	Agency	(UKAD)	from	the	World	
Anti-Doping	 Agency	 (WADA)	 regarding	 its	 status	 in	 relation	 to	 the	 WADA	 code.	
Following	the	submission	of	a	detailed	dossier,	including	the	GRAS	documentation,	





All	 cycle	 ergometry,	 except	 for	 that	 used	 in	 the	 repeat	 sprint	 trial	 following	 pre-
fatigue,	was	conducted	on	an	electro-magnetically	braked	stationary	cycle	ergometer	
(SRM	Ergometer	equipped	with	a	Science	PowerMeter,	Schoberer	Rad	Messtechnik,	
Jülich,	 Germany).	 The	 ergometer	 was	 calibrated	 before	 and	 after	 each	 trial	 in	 a	
modified	 version	 of	 published	 guidelines	 (Wooles,	 Robinson,	 &	 Keen,	 2005).	
Manufacturer	reported	measurement	error	for	the	Science	PowerMeter	is	±	0.5%.	
However,	a	more	rigorous	calibration	standard	of	less	than	±	0.1%	can	be	achieved	
with	 further	 control	 of	 the	 calibration	 procedure.	 The	 method	 of	 calibration	
employed	here	adopted	elements	of	the	published	method,	such	as	making	multiple	
measurements	at	multiple	crank	angles,	but	did	not	employ	a	precision	machined	





















(WattBike	 Pro,	 Nottingham,	 UK).	 WattBikes	 were	 factory	 calibrated	 with	
manufacturer	reported	accuracy	better	than	±	2.0%	in	the	range	100-200W,	better	
than	±	1.5%	in	the	range	200-500W	and	better	than	±	1.0%	at	power	outputs	above	
500W.	 Test-retest	 reliability	 of	 an	 individual	 30-second	 maximal	 sprint	 on	 the	
WattBike	has	been	examined	in	trained	cyclists	with	a	reported	CV	of	2.4%	for	mean	




For	 both	 ergometers	 (SRM	 Ergometer	 &	 WattBike	 Pro)	 each	 participant’s	 riding	
position	was	customised	to	 individual	 rider	preference	by	adjusting	the	horizontal	
and	vertical	alignment	of	both	the	saddle	and	the	handlebars.	The	preferred	setup	














(Harvard	 Apparatus,	 Kent,	 UK),	 temperature	 of	 expired	 gases	 via	 a	 digital	





by	 prior	 gravimetric	 analysis	 (British	 Oxygen	 Company,	 UK).	 Douglas	 bags	 were	
checked	 for	 leakage	 and	 evacuated	 under	 negative	 pressure	 prior	 to	 each	 usage.	
Measured	values	were	used	to	determine	ventilatory	rate	(VE),	the	rate	of	oxygen	
consumption	(VO2)	and	the	rate	of	carbon	dioxide	production	(VCO2)	and	corrected	




Capillary	blood	 samples	were	collected	 from	an	earlobe	as	designated	 in	 the	 trial	





rapid	 insertion	 and	 withdrawal	 of	 a	 sterile	 lancet	 (Accu-Chek	 Safe-T-Pro,	 Roche,	
Basel,	 Switzerland)	 with	 the	 earlobe	 held	 under	 tension.	 Free	 flowing	 blood	was	
collected	from	the	puncture	site	either	by	capillary	action	as	described	below	or	by	
passive	 draw	 into	 a	 0.5ml	 EDTA	 sample	 bucket	 (Microvette	 500,	 Sarstedt,	
Nümbrecht,	 Germany).	 EDTA	 samples	 were	 refrigerated	 immediately	 and	
centrifuged	(Heraeus	Biofuge	Pico,	Thermo-Scientific,	Waltham,	USA)	for	10	minutes	
as	soon	as	possible	after	collection.	The	plasma	portion	of	each	sample	was	extracted	
using	 a	 positive	 displacement	 pipette	 (Biohit	 Proline	 Plus	 Mechanical	 Pipette,	
Sartorius,	 Helsinki,	 Finland)	 and	 redistributed	 into	 polypropylene	 sample	 tubes	






upper	arm	and	adjusted	 to	a	 level	of	 tightness	 that	encouraged	protrusion	of	 the	
distal	superficial	veins	without	causing	loss	of	sensation	or	excessive	discomfort.		A	




For	 the	 venepuncture	 procedure	 a	 butterfly	 needle	 with	 a	 syringe	 attached	










For	 the	 cannulation	 procedure	 a	 venous	 cannula	 needle	 (Venflon	 Pro,	 BD,	 New	
Jersey,	USA)	was	advanced	through	the	skin	and	into	the	designated	vein.	Flush	back	
of	blood	into	the	cannula	sheath	was	used	to	guide	the	insertion	of	the	needle.	Once	













Venous	 samples	 were	 immediately	 transferred	 into	 either	 EDTA	 (EDTA	 KE/5ml,	
Sarstedt,	 Nümbrecht,	 Germany)	 or	 serum	 (Serum	 Gel/5ml,	 Sarstedt,	 Nümbrecht,	
40	
	
Germany)	 collection	 tubes.	 EDTA	 samples	 were	 refrigerated	 immediately	 and	
centrifuged	 (Heraeus	 Biofuge	 Primo	 R,	 Thermo-Scientific,	 Waltham,	 USA)	 for	 10	
minutes	as	soon	as	possible	after	collection.	The	plasma	portion	of	each	sample	was	
extracted	 using	 a	 positive	 displacement	 pipette	 (Biohit	 Proline	 Plus	 Mechanical	
Pipette,	 Sartorius,	 Helsinki,	 Finland)	 and	 redistributed	 into	 polypropylene	 sample	
tubes	(1.5ml	Microcentrifuge	Safe-Lock	Tubes,	Fischer	Scientific,	Loughborough,	UK).	
Serum	samples	were	left	at	room	temperature	for	15	minutes	and	then	centrifuged	
(Heraeus	 Biofuge	 Primo	 R,	 Thermo-Scientific,	 Waltham,	 USA)	 at	 1500g	 for	 10	
minutes.	 The	 serum	 portion	 of	 each	 sample	 was	 extracted	 using	 a	 positive	
displacement	 pipette	 (Biohit	 Proline	 Plus	 Mechanical	 Pipette,	 Sartorius,	 Helsinki,	
Finland)	and	redistributed	into	polypropylene	sample	tubes	(1.5ml	Microcentrifuge	





point	 of	 collection	 using	 a	 handheld	 monitor	 employing	 a	 microfluidic	 strip	
technology	 (Optium	 Xceed	 and	 ß-ketone	 strips,	 Abbott	 Laboratories	 Ltd,	
Maidenhead,	UK).	For	capillary	earlobe	samples,	a	 test	strip	was	 inserted	 into	the	
monitor	and	the	tip	of	the	strip	was	presented	to	a	blub	of	fresh	blood	formed	at	the	
base	 of	 the	 earlobe.	 A	 small	 volume	 of	 blood	 (10µl)	was	 drawn	 into	 the	 strip	 by	
capillary	action	and	the	monitor	reported	a	test	result	within	10	seconds.	For	venous	
samples	 the	 tip	of	 the	 test	strip	was	presented	to	 the	 tip	of	 the	syringe	 following	











capillaries	 (Clinitubes,	 Radiometer,	 Brønshøj,	 Denmark)	 by	 capillary	 action	 from	a	
blub	of	fresh	blood	formed	at	the	base	of	the	earlobe.	Samples	were	agitated	by	hand	
for	30	seconds	prior	to	being	presented	to	an	automated	blood	gas	analyser	(ABL	70,	





1974).	 Calibration	 of	 the	 Radiometer	 ABL	 70	 involved	 an	 automated	 procedure	
utilising	a	calibration	cassette	pre-filled	with	standard	solutions	in	the	physiological	
range	 for	 each	 parameter.	 In	 addition	 to	 instrument	 calibration	 a	 quality	 control	
procedure	was	conducted	prior	to	each	test	session.	Four	different	quality	control	
solutions	 across	 the	 physiological	 range	 (Qualicheck+,	 Radiometer,	 Brønshøj,	
Denmark)	 were	 presented	 to	 the	 device	 and	 checked	 against	 factory-calibrated	





without	 the	 need	 for	 an	 invasive	 and	 painful	 procedure,	 with	 the	 earlobe	 the	
preferred	site	of	sample	collection	(Zavorsky,	Cao,	Mayo,	Gabbay,	&	Murias,	2007).	
However,	 the	 measured	 values	 demonstrate	 a	 loss	 of	 accuracy	 and	 reliability	





On	 the	day	of	 analysis	 frozen	 samples	were	 fully	 defrosted	 to	 room	 temperature	
(~20°C)	 and	 partitioned	 for	 analysis	 by	 multiple	 assays	 as	 indicated	 in	 the	 trial	
schedule.	 Samples	 were	 analysed	 for	 concentrations	 of	 glucose,	 lactate,	 non-
esterified	fatty	acids	(NEFA),	Glycerol	and	ß-hydroxybutyrate	by	spectrophotometry	
(RX	Daytona,	Randox,	Crumlin,	UK)	and	by	commercial	ELISA	kits	for	concentrations	
of	 insulin	 (Mercodia,	 Uppsala,	 Sweden),	 total	 testosterone,	 free	 testosterone,	
dihydrotestosterone	and	cortisol	(IBL,	Hamburg,	Germany).	For	the	repeat	sprint	trial	
(Chapter	 7)	 plasma	 samples	 were	 analysed	 for	 dihydrotestosterone	 using	 an	


















gastrointestinal	 symptom	 scale	 (Appendix	 5)	 was	 used	 to	 determine	 GI	 comfort	

















min	 exercise	 15-min	 post	 dose	 (E15),	 30-min	 exercise	 45-min	 post	 dose	 (E45)).	












conclusion,	 meal	 timing	 and	 drink	 composition,	 but	 not	 warm-up	 exercise,	 are	










dietary	 provision	 of	 carbohydrate	 and	 fat	 as	 exogenous	 substrate	 for	 exercise	
(Hargreaves	 et	 al.,	 2004)	 and	 the	 dietary	 provision	 of	 protein	 for	 post-exercise	
recovery	(Burd,	Tang,	Moore,	&	Phillips,	2009).	However,	the	emergence	of	a	novel	
method	for	achieving	nutritional	ketosis	through	consumption	of	a	ketone	ester	drink	
brings	 into	 consideration	 a	 fourth	 macronutrient	 with	 the	 potential	 to	 influence	
exercise	metabolism	(Kashiwaya	et	al.,	2010).		
	
Ketone	 ester	 consumption	 has	 been	 shown	 to	 be	 safe	 and	 effective	 at	 rapidly	
inducing	a	moderate	ketosis	under	 laboratory	 conditions	 (Clarke	et	al.,	 2012)	and	










One	 of	 the	 critical	 advantages	 of	 nutritional	 ketosis	 achieved	 via	 ketone	 ester	
consumption	 is	 the	 avoidance	 of	 the	 carbohydrate	 restriction	 employed	 in	 the	
ketogenic	diet	(Hashim	&	Vanitallie,	2014).	The	prospect	of	co-administering	a	ketone	
ester	alongside	carbohydrate	is	likely	to	confer	benefit	both	to	the	optimisation	of	
























dose	 of	 ketone	 ester	 under	 randomised	 conditions	 varying	 either	 the	 feeding	
strategy	in	the	feeding	trial	cohort	or	the	‘warm	up’	exercise	strategy	in	the	exercise	


























ketone	bodies	 further	 samples	were	collected	 immediately	pre	ketone	ester	dose	
and	at	the	following	time	points	post	dose:	15mins,	30mins,	45mins,	60mins,	90mins,	
120mins,	150mins,	180mins,	240mins,	300mins.	Blood	samples	were	centrifuged	and	














90-minutes	prior	 to	 the	ketone	ester	dose.	Ketone	ester	was	provided	as	a	 single	
bolus	 in	 a	 drink	 containing	 a	 1:1	 calorie	 ratio	 of	 ketone	 ester	 and	 carbohydrate	
(400mg/kg-body-mass	 Ketone	 ester	 +	 480mg/kg-body-mass	 carbohydrate).	
Participants	were	advised	to	sit	at	rest	for	the	ensuing	300-minutes	post	dose	with	

















30-minutes	 of	 exercise	 was	 conducted	 commencing	 15-minutes	 after	 the	 ketone	
ester	dose.	Exercise	consisted	of	30	minutes	of	sub-maximal	cycle	ergometry,	at	a	
self-selected	intensity	based	on	a	guidance	rating	of	perceived	exertion	of	11	(‘Fairly	
Light’)	 interspersed	with	 four	 10-second	 sprints	 at	 a	 guidance	 rating	of	 perceived	
exertion	of	17	(‘Very	Hard’)	performed	at	minutes	10,	15,	20	and	25	of	the	exercise	







All	 trial	 data	were	 subjected	 to	 non-compartmental	 analysis	 of	 plasma	data	 after	
extravascular	input	in	order	to	determine	the	pharmacokinetic	parameters	of	plasma	







An	 analysis	 of	 variance	 (ANOVA)	 was	 used	 to	 identify	 differences	 between	
treatments	 for	 pharmacokinetic	 parameters,	 and	 a	 two-way	 (treatment	 x	 time)	
general	liner	model	for	repeated	measures	was	used	to	identify	differences	over	time	
in	 outcome	 variables.	 The	 Greenhouse–Geisser	 correction	 was	 used	 for	 epsilon	
<0.75,	while	 the	Huynh–Feldt	 correction	was	 adopted	 for	 less	 severe	 asphericity.	
Where	significant	F	values	were	found,	the	Holm–Bonferroni	stepwise	correction	was	
applied	to	determine	the	location	of	variance.	All	statistical	analysis	was	conducted	
























































































































































































































	 	 	 Feeding	Cohort	 	
	 Exercise	
Cohort	 	
	 Trial	F90	(All)	 Trial	F90	 Trial	F30	 Trial	F4:1	 Trial	F90	 Trial	E15	 Trial	E45	
Cmax	(mmol/l)	 3.4	±	0.5	 3.5	±	0.5	 2.8	±	0.4
+
	 4.1	±	0.7
**	 3.2	±	0.4	 3.2	±	0.9	 3.0	±	0.4	
Tmax	(mins)	 57.0	±	13.8	 63.0	±	6.7	 75.0	±	10.6	 51.0	±	17.1	 51.0	±	17.1	 69.0	±	8.2	 60.0	±	28.1	
t1/2	(mins)	 73.2	±	17.3	 75.8	±	25.5	 58.2	±	10.4	 62.0	±	7.2	 70.6	±	3.1	 66.3	±	11.8	 76.4	±	13.2	
AUC:	0-inf	
(mmol/l˚min)	 490.2	±	108.9	 486.7	±	117.2	 438.5	±	83.5	 536.2	±	120.8	 493.6	±	113.6	 461.1	±	136.9	 457.2	±	109.2	
AUC:	0-90	
(mmol/l˚min)	 	 260.7	±	33.6	 201.9	±	33.4
*	 311.4	±	49.3*	 	 	 	
AUC:	15-45	
(mmol/l˚min)	 	 	 	 	 81.3	±	8.0	 65.4	±	18.4	 78.6	±	10.0	
AUC:	45-75	






























after	 ketone	 ester	 consumption.	 These	 factors	 are	 important	 elements	 of	







approximately	 four	 hours,	 in	 the	 absence	 of	 strenuous	 exercise.	 This	 response	
pattern	provides	a	reliable	platform	for	advice	regarding	the	timing	of	ketone	ester	
intake	for	sports	performance	with	a	timeframe	of	~30-90-minutes	post	ketone	ester	







Given	 the	 potential	 for	 gastric	 intolerance	 with	 exercise	 feeding	 strategies,	 and	
preliminary	evidence	 that	 the	consumption	of	ketone	esters	may	 result	 in	gastro-
intestinal	 (GI)	 side	 effects	 (Clarke	 et	 al.,	 2012),	 the	 timing	 of	 ketone	 ester	





the	 field	 and	 to	mitigate	 for	 the	 know	effects	 of	 breakfast	 consumption	on	post-
prandial	 metabolism	 (Gonzalez,	 Veasey,	 Rumbold,	 &	 Stevenson,	 2013).	 Whilst	 a	
favourable	 release	profile	was	 seen	when	 ketone	ester	was	delivered	90-minutes	
after	breakfast	 this	may	not	be	practical	 in	all	 sports	 settings	where	a	number	of	
factors	will	influence	pre-exercise	feeding	strategy	(Ormsbee,	Bach,	&	Baur,	2014).		
	
Reducing	 the	 extent	 of	 carbohydrate	 co-dosing	 with	 ketone	 ester	 consumption	
resulted	here	in	a	more	rapid	release	profile	with	a	higher	peak	BHB	concentration	
(Table	3.1).	Whilst	this	may	be	desirable	in	some	circumstances	it	is	likely	that	most	
practical	 ketone	 ester	 dosing	 strategies	 will	 favour	 an	 optimal	 carbohydrate	 co-









sports	 performance	 (Fig.3.1C).	 Were	 a	 significantly	 more	 vigorous	 warm-up	








the	 translational	 value	 of	 promising	 ergogenic	 interventions	 evidenced	 in	 a	
laboratory	context	for	utility	in	the	field.	The	effects	described	here	of	a	slowing	of	
the	 accumulation	 of	 circulating	 ketone	 bodies	 when	 ketone	 ester	 dosing	 occurs	
sooner	after	a	meal	and	a	more	rapid	accumulation	of	circulating	ketone	bodies	with	








A	 novel	 ketone	 ester	 drink	 has	 been	 developed	 that	 shows	 benefit	 to	 exercise	
energetics	 and	 endurance	 performance	 in	 trained	 athletes	 (Cox	 et	 al.,	 2016).	
However,	ketone	ester	consumption	comes	with	a	significant	side	effect	profile	of	




metabolism	 and	 cycling	 performance	 during	 a	 mixed-demand	 100-min	 effort	
followed	 by	 a	 20km	 time	 trial	 (TT),	 when	 compared	 to	 a	 calorie-matched	




±	113.0s	v	1736.9	±	114.2s)	although	 there	was	a	 small	 trial	order	effect.	Altered	
perceptions	 of	 effort	 (P<0.05)	 and	 affect	 (P<0.05)	 during	 the	 100-min	 effort	
correlated	with	the	change	in	TT	performance.	In	conclusion,	low	dose	ketone	ester	





A	 novel	 dietary	 ketone	monoester	 has	 recently	 been	 developed	 that	 can	 rapidly	
induce	a	moderate	ketosis	and	in	doing	so	offer	a	novel	alternate	source	of	energetic	
substrate	that	would	not	normally	be	available	during	exercise	in	a	eucaloric	feeding	
state	 (Clarke	 et	 al.,	 2012).	 Ketone	 bodies	 are	 excellent	 fuel	 sources	 with	 rapid	
availability	 and	 excellent	mitochondrial	 efficiency.	 Acute	 ingestion	 of	 this	 ketone	
ester	has	been	shown	(unpublished	data	from	our	group)	to	exert	a	positive	impact	
on	athletic	performance	in	high	performance	athletes,	both	in	rowers	during	a	30’	
rowing	 ergometer	 distance	 trial	 and	 in	 rugby	 players	 during	 an	 84’	 rugby	 game	










number	 of	 studies	 have	 shown	 that	 long	 duration	 exercise	 performance	 can	 be	
influenced	by	a	variety	of	acute	 feeding	 strategies	 that	alter	exogenous	 substrate	












In	 the	 search	 for	 explanatory	 factors	 in	 defining	 this	 performance	 variance	 the	
concept	of	pacing	for	optimal	performance	has	emerged	(Tucker	&	Noakes,	2009).	It	
















This	 study	 aimed	 to	 determine	 whether	 supplemental	 ketosis	 via	 ketone	 ester	
feeding,	at	a	lower	dose	than	utilised	previously,	could	improve	long	duration	cycling	
performance	 without	 significant	 gastrointestinal	 side	 effects	 in	 highly	 trained	
endurance	 athletes	 compared	 to	 current	 best	 practice	 macronutrient	 feeding	




















This	 study	 followed	 a	 double-blinded,	 randomised	 cross-over	 design.	 Participants	
attended	the	laboratory	on	three	occasions	each	separated	by	5-8	days.	On	the	first	
preliminary	 trial	 day	 all	 participants	performed	an	 incremental	 cycle	 exercise	 test	
followed,	after	one	hour	of	recovery,	by	a	20km	time	trial	with	the	aim	of	determining	
participant	work	 capacity	 and	 aerobic	 fitness	whilst	 also	 achieving	 familiarisation	
with	the	test	procedure	for	subsequent	trials.	On	the	following	two	main	trial	days	a	



















An	 exhaustive	 incremental	 exercise	 test	 was	 performed	 on	 the	 cycle	 ergometer	
(SRM)	 for	 the	 determination	 of	 maximal	 oxygen	 uptake	 (VO2max)	 and	 maximum	
power	output	 (Wmax).	Expired	gases	were	collected	 in	 the	 final	minute	of	exercise	
using	a	Douglas	bag	and	subsequently	analysed	for	volume	of	air	expired	using	a	dry	
gas	 meter	 (Harvard	 Apparatus,	 UK),	 temperature	 of	 expired	 gases	 via	 a	 digital	
thermometer	(model	C,	Edale	Instruments,	UK)	and	fractional	concentrations	of	O2	
and	CO2	using	paramagnetic	and	infra-red	methods,	respectively	(Servoflex	MiniMP,	































arrival	 at	 the	 laboratory.	Upon	arrival	 baseline	blood	 samples	were	 collected	and	
participants	were	fitted	with	a	body	sensor	network	garment	(Hidalgo	Equivital)	for	
the	 continuous	measurement	of	heart	 rate,	 breathing	 rate,	 skin	 temperature	and	
core	temperature	(via	telemetry	from	a	thermometric	pill	ingested	four	hours	before	
the	 trial;	 Philips	 VitalSense).	 Participants	 then	 completed	 a	 100-minute	 pre-load	

















buckets	 (Microvette	500,	 Sarstedt,	Nümbrecht,	Germany).	 Samples	were	 taken	at	
baseline	and	then	immediately	prior	to	and	each	20	minutes	block	throughout	the	







at	 -80oC	 for	 later	 analysis	 of	 glucose,	 lactate,	 glycerol	 and	 free	 fatty	 acids.	 Blood	





samples	 were	 drawn	 into	 pre-treated	 heparin	 glass	 capillaries	 (Clinitubes,	
Radiometer,	 Brønshøj,	 Denmark)	 by	 capillary	 action	 from	 a	 blub	 of	 fresh	 blood	
formed	at	the	base	of	the	earlobe.	Samples	were	agitated	by	hand	for	30	seconds	







pre-load	 exercise	 period.	 Expired	 gas	 samples	 were	 analysed,	 following	 the	
procedures	 described	 in	 the	 incremental	 exercise	 test,	 for	 the	 determination	 of	


















a	 two-way	 (treatment	 x	 time)	 general	 liner	 model	 for	 repeated	 measures	 was	
employed	 for	all	 serial	measures,	with	 the	Greenhouse-Geisser	correction	applied	
where	 assumptions	 of	 sphericity	 were	 violated.	 Main	 effects	 were	 isolated	 by	
pairwise	multiple	comparisons	using	the	Bonferroni	method.	Treatment	effects	on	
time	trial	performance	were	compared	to	overall	time	trial	performance	using	Bland	
Altman	 plots	 and	 compared	 with	 treatment	 effects	 for	 independent	 variables	
(objective	 and	 subjective	 data)	 by	 correlation	 analysis.	 All	 statistical	 analysis	 was	
68	
	





Participant	 fitness	 (Table	 4.1A)	 was	 demonstrated	 by	 a	 group	 average	maximum	
minute	 power	 of	 400.4	 ±	 34.6W	 and	 body	 weight	 corrected	 maximal	 oxygen	
consumption	of	64.4	±	6.1ml/kg/min.	All	participants	were	self-rated	as	either	a	well-









	 	 	 	 	 	 	
A	 	 Age	 Height	 Weight	 	 	
	 Ave	 29.8	 183.4	 74.9	 	 	
	 SD	 ±	6.5	 ±	5.5	 ±	6.9	 	 	
	 	 	 	 	 	 	
	 1'	Wmax	 VO2max	 20km	TT	
	 (W)	 (L/min)	 (ml/kg/min)	 (mm:ss.0)	 (W)	 (W/kg)	
Ave	 400.4	 4.8	 64.4	 27:00.7	 302.7	 4.06	
SD	 ±	34.6	 ±	0.2	 ±	6.1	 ±	01:12.6	 ±	30.2	 0.46	
	 	 	 	 	 	 	














Ave	 12.9	 6.4	 5.4	 10.3	 	
SD	 7.1	 1.8	 2.2	 3.0	 	





















taken	 to	 complete	 the	 first	 main	 trial	 (Trial	 A;	 n=12	 male	 cyclists).	 Closed	 symbols	 represent	

















































body	 concentration	 throughout	 exercise	 resulting	 in	 average	 blood	 ketone	 body	
concentration	in	the	ketone	ester	(KET)	trial	of	1.29	±	0.39mmol/l.	There	were	also	



























were	 of	 sufficient	 quality	 for	 inclusion	 in	 the	 study.	 As	 a	 result,	 no	 analysis	 was	




time	make	 reliable	 data	 capture	 unpredictable	with	 the	 result	 that	 a	 significantly	




















unpleasant)	 than	 the	 carbohydrate	 (CHO)	 trial	 drink	 (neutral	 to	 moderately	
unpleasant),	although	there	were	a	wide	range	of	individual	ratings	(KET	v	CHO:	40.4	
±	7.3	v	49.7	±	6.6;	P<0.001).	
Mild	 to	 moderate	 GI	 symptoms	 presented	 on	 both	 treatments	 in	 a	 minority	 of	
participants	but	with	no	clear	effect	of	treatment	or	trial	order	(Fig	4.5).	
	


































































mixed-intensity	 submaximal	 cycling.	 This	 observation	 was	 confounded	 by	 a	 trial	






the	 gastrointestinal	 side	 effects	 associated	 with	 ester	 consumption.	 Whilst	 this	
77	
	




a	sustained	ketosis	but	at	a	 lower	 level	 (1.29	±	0.39mmol/l)	 than	that	achieved	 in	





a	 significant	 impact	 on	 circulating	 lipid	 metabolites	 during	 the	 pre-load	 exercise	
period	 suggesting	 that	 exercising	 substrate	 selection	was	 altered	 by	 ketone	 ester	
treatment.	 The	 accumulation	 over	 time	 of	 blood	NEFA	 and	Glycerol	 levels	 in	 the	
carbohydrate	(CHO)	trial	was	consistent	with	previously	published	observations	of	a	
switch	 in	substrate	selection	 towards	an	 increase	 in	 fat	oxidation	and	decrease	 in	
carbohydrate	 oxidation	 over	 time	 with	 prolonged	 exercise	 (J	 a	 Romijn,	 Coyle,	
Sidossis,	Rosenblatt,	&	Wolfe,	2000).	This	view	was	further	supported	by	a	drop	in	










each	 of	 these	 compounds	 has	 an	 RQ	 somewhere	 between	 that	 of	 fat	 and	
carbohydrate,	rendering	such	estimation	methods	invalid.	It	would	be	of	significant	
value	 to	 quantify	 rates	 of	 substrate	 oxidation	 in	 the	 presence	 of	 ketosis	 during	
exercise	by	conducting	isotopic	tracer	studies.	
The	low	level	ketosis	seen	here	was	not	sufficient	to	significantly	alter	blood	glucose	




that	 seen	 in	 previous	 studies	 resulting	 in	 significantly	 lower	 levels	 of	 circulating	
lactate.	Whilst	the	lower	dose	ketosis	itself	cannot	be	ruled	out	as	a	factor	in	the	lack	
of	an	ergogenic	effect	in	the	current	trial,	it	remains	possible	that	a	higher	level	of	













Brooks,	 2009).	 Indeed,	 recently	 attempts	 have	 been	 made	 to	 positively	 impact	








That	 differences	 in	 volitional	 water	 intake	 related	 to	 differences	 in	 time	 trial	
performance	across	 trials	may	be	 indicative	of	 this	and	perhaps	point	 towards	an	
acclimation	 to	 the	moderate	 thermal	 load	with	 repeat	 trialling	as	 a	moderator	of	
performance	in	the	current	trial	(Guy,	Deakin,	Edwards,	Miller,	&	Pyne,	2015).		
	
However,	 there	 were	 no	 differences	 between	 the	 first	 and	 second	 trials	 in	 skin	
temperature,	 heart	 rate,	 blood	 metabolites	 or	 any	 gas	 exchange	 variable.	
Irrespective	of	treatment	an	improvement	in	time	trial	performance	was	associated	
with	lower	levels	of	perceived	exertion	and	higher	levels	of	affect	during	the	pre-load	
exercise	 period.	 Given	 the	 highly	 subjective	 nature	 of	 pacing	 for	 volitional	
performance	 and	 the	 absence	 of	 any	 objective	 performance	 feedback	 during	 the	
time	trials	these	subjective	relationships	are	unsurprising	but	likely	indicate	some	of	
the	common	 factors	which	 lead	 to	natural	variance	 in	 repeat	performance	of	 this	
type	of	exercise	 task	 in	other	 settings	 (Sharma,	Elliott,	&	Bentley,	2015).	That	 the	






It	 is	 possible	 that	 perceived	 differences	 in	 the	 pleasantness	 of	 the	 trial	 drinks	




performance,	 regardless	 of	 which	 drink	 provoked	 more	 symptoms	 for	 a	 given	
participant,	 however	 there	 was	 no	 overall	 difference	 in	 symptom	 appearance	
between	treatments.	Whilst	the	lower	dosing	used	in	the	current	trial	may	therefore	




effects	 without	 derailing	 performance.	 There	 is	 evidence	 that	 more	 successful	
athletes	 in	 real	world	 endurance	 events	 tolerate	 higher	 levels	 of	GI	 symptoms	 in	











during	 long	 duration	 cycling,	 by	 dampening	 exercise	 induced	 elevations	 in	 serum	
NEFA	and	glycerol,	but	did	not	have	any	impact	at	the	dose	delivered	on	20km	cycling	
time	trial	performance	 following	an	extensive	pre-fatigue	protocol.	Future	studies	
should	examine	 the	dose	 response	 to	 ketone	ester	 consumption	 in	 relation	 to	 its	
impact	upon	substrate	selection	at	different	intensities	and	for	different	durations	of	










Dihydrotestosterone	 (DHT)	exerts	both	 functional	 and	 signalling	effects	 extending	















DHT	 is	 acutely	 elevated	 following	 sprint	 cycle	 exercise	 and	 that	 this	 response	 is	











these	 actions,	 including	 the	 activation	 of	 cell	 signalling	 pathways	 promoting	 the	
mobilisation	 of	 energy	 reserves	 via	GLUT4	 (Sato	 et	 al	 2008)	 and	 the	 accretion	 of	
protein	 for	 skeletal	muscle	hypertrophy	 (Ferrando	et	 al	 2002)	 via	mTor	 (Wu	et	 al	
2010),	modulation	of	the	excitability	of	neuro-motor	units	(Bonifazi	et	al	2004)	and	
more	 complex	 influences	 on	 behavioural	motivation	 (Archer	 2006)	 and	 cognition	
(Aleman	 et	 al	 2004).	 However,	 the	 precise	 nature	 of	 the	 interaction	 between	
hormonal	 response	 and	 functional	 outcome	 in	 a	 given	 exercise	 setting	 remains	
poorly	 understood.	 In	 particular	 the	 reliance	 upon	 testosterone	 as	 a	 ubiquitous	




DHT	 is	 considered	 the	 terminal	 active	 product	 of	 androgen	 biosynthesis,	 being	
produced	 via	 both	 testosterone	 dependent	 and	 independent	 pathways	 (Yarrow,	
McCoy	&	Borst	 2012).	 Compared	 to	 testosterone,	DHT	has	 greater	 affinity	 to	 the	







smaller	 quantities	 than	 other	 androgens	 (Luu-The	 &	 Laberie	 2010;	 Penning	 et	 al	
2000).	This	regulation	may	serve	in	part	to	limit	adipogenic	actions	that	have	seen	
chronically	elevated	DHT	levels	linked	to	metabolic	and	cardiovascular	disease	risk	
(Duskova	 &	 Pospisilova	 2011).	 Given	 its	 heightened	 androgenic	 potency,	 the	
enzymatic	 machinery	 required	 for	 bioconversion	 of	 androgens	 to	 DHT	 is	 not	
universally	 distributed,	 allowing	 tissue	 specific	 effects	 only	 in	 selected	 androgen	
sensitive	tissues	(Thigpen	et	al	1993).		
	




variety	 of	 transcriptional	 events	 associated	 with	 anabolism	 via	 classical	 genomic	
signalling	(Yoshioka	et	al	2006).	Historically,	human	skeletal	muscle	was	not	thought	
to	 contain	 significant	 levels	 of	 the	 5α-reductase	 responsible	 for	 conversion	 of	
testosterone	 to	 DHT	 (Thigpen	 et	 al	 1993).	 However,	 this	 view	 has	 recently	 been	








muscle	 function.	 The	 purpose	 of	 the	 current	 study	 was	 therefore	 to	 determine	
whether	 circulating	 DHT	 is	 acutely	 elevated	 in	 a	 group	 of	 exercise	 trained	 men	
performing	repeat	sprint	exercise	that	involves	sustained	recruitment	of	fast	twitch	























Incremental	 exercise	 trial:	 In	 order	 to	 determine	 participant	 fitness	 and	 to	 set	
workloads	for	subsequent	sprint	exercise,	all	participants	undertook	an	incremental	
exercise	 test	 to	 exhaustion	 on	 a	 stationary	 cycle	 ergometer	 (Schoberer	 Rad	

















completed	 a	 bout	 of	 sprint	 interval	 cycle	 exercise	 on	 the	 stationary	 ergometer	
(Schoberer	 Rad	 Messtechnik,	 SRM,	 Germany),	 consisting	 of	 10	 repetitions	 of	 30	











exercise	 sample,	 further	 samples	were	 collected	 5	minutes	 post-	 and	 60	minutes	
post-exercise.	 Samples	were	 suspended	 in	 serum	 collection	 tubes	 (Serum	Z/5	ml,	
Sarstedt,	Germany)	for	15	minutes	before	being	centrifuged	for	10	minutes	at	1500g.	














Demographic	 comparisons	 between	 athlete	 groups	 were	 conducted	 by	 one-way	
analysis	of	variance	 (ANOVA)	and	hormonal	 responses	were	analysed	using	a	 two	
way	(group	x	time)	repeated	measures	general	linear	model,	with	the	Greenhouse-
Geisser	 correction	 applied	 where	 assumptions	 of	 sphericity	 were	 violated.	 Main	
effects	were	isolated	by	pairwise	multiple	comparisons	using	the	Bonferroni	method.	
All	hormonal	data	were	normalized	by	natural	log	transformation	prior	to	analysis.	
Hormonal	 changes	 from	 pre	 to	 post	 exercise	 for	 different	 androgens	 were	 then	
examined	for	correlation	to	each	other	and	to	demographic	and	sprint	performance	
data	by	Pearson	product	moment	correlation.	All	statistical	analysis	was	conducted	











Wmax	 (P	 =	 0.002)	 calculated	 during	 the	 incremental	 exercise	 protocol	 were	
significantly	higher	for	competitive	compared	to	recreational	athletes.	Competitive	


















The	 competitive	 group	 completed	 the	 sprint	 task	 at	 the	 target	 load	 of	 150%	 of	
measured	 work	 capacity	 (average	 power:	 149.4	 ±	 10.1%	 Wmax).	 However,	 the	
90	
	
recreational	group	were	 less	able	 to	sustain	 the	 target	 load	 for	all	 ten	 repetitions	
(average	power:	135.3	±	15.5%	Wmax)	although	the	difference	between	groups	did	
not	reach	significance	(P	=	0.066).	As	a	result,	competitive	athletes	performed	at	a	






















All	 hormonal	 responses	were	 compared	 in	 relation	 to	 competitive	 status	 and	 no	


































this	 relationship	 appears	 to	 depend	 upon	 training	 status	 (Crewther	 et	 al	 2012a).	
Whether	 these	 modulatory	 effects	 of	 training	 extend	 to	 the	 activation	 of	 5α-
reductase	 in	exercising	 skeletal	muscle	 is	not	yet	known.	Modulatory	 increases	 in	
skeletal	muscle	DHT	levels	in	response	to	exercise	training	have	recently	been	shown	
in	 rodents	 (Aizawa	et	 al	 2011)	 and	 chronic	 up-regulation	of	 basal	 circulating	DHT	
levels	with	training	has	also	been	reported	in	humans	(Hawkins	et	al	2008).	However,	
acute	 exercise	 responses	 were	 not	 reported.	 In	 the	 present	 study	 a	 significant	









other	mixed	ability	athletic	 groups,	 suggesting	 that	androgen	 responsiveness	may	
only	 be	 pertinent	 to	 functional	 output	 in	 a	 subgroup	 of	 athletes	 (Crewther	 et	 al	
2012a;	Crewther	et	al	2012b).	Future	studies	should	examine	acute	DHT	responses	
to	 exercise	 in	 less	 well	 trained	 or	 sedentary	 individuals	 as	 well	 as	 exploring	 the	





of	 responsiveness	 to	 the	 sprint	 stimulus	 of	 all	 three	 of	 the	measured	 androgens,	
including	 DHT.	 Whilst	 lacking	 causation,	 this	 correlation	 points	 towards	 the	






holds	with	 the	age	related	decline	of	muscle	 function	 in	older	men	(Pearson	et	al	
2006).	At	the	cellular	level	DHT	has	been	shown	to	increase	transcriptional	signalling	
of	factors	involved	in	ATP	production	and	calcium	cycling	in	mouse	skeletal	muscle	
(Yoshioka	 et	 al	 2006).	 In	 the	 rat,	 cultured	 skeletal	 muscle	 cells	 exposed	 to	
testosterone	 or	 dehydroepiandrosterone	 (DHEA)	 exhibit	 a	 DHT	 conversion	
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dependent	 enhancement	 of	 glucose	metabolism	by	 increasing	 protein	 expression	
and	translocation	of	GLUT-4	(Sato	et	al	2008)	and	administration	of	DHT	to	isolated	
muscle	 fibre	 bundles	 enhances	 contractile	 function,	 but	 only	 in	 fast	 twitch	 fibres	
(Hamdi	&	Mutungi	2010).	 It	 is	possible	 therefore	that	 the	androgenic	 response	to	









driving	this	 response.	 In	support	of	 this	view,	preliminary	 findings	 from	our	group	
indicate	 that	 elevations	 in	 DHT	 can	 also	 be	 detected	 in	 human	muscle	 dialysate	
during	high	intensity	exercise	(unpublished	data).	In	rodents	exercise	has	been	shown	
to	 promote	 active	 bioconversion	 of	 androgens	 by	 skeletal	 muscle	 resulting	 in	








data	 directly	 supporting	 these	 claims	 in	 normal,	 healthy	 humans	 is	 scarce	 in	 the	
available	 literature,	 with	 inferences	 regarding	 5α-reductase	 inactivity	 largely	
dependent	 upon	 observations	 of	 normal	 muscular	 development	 in	 patients	 with	
congenital	5α-reductase	deficiency	(Gormley	1995;	Rittmaster	1994),	and	evidence	
of	sustained	muscle	hypertrophy	during	exogenous	testosterone	administration	 in	





of	 a	 third	 isoenzyme	 of	 5α-reductase	 that	 shows	 an	 expression	 profile	 in	 human	
skeletal	muscle	(Godoy	et	al	2011,	Yamana,	Labrie	&	Luu-The	2010).	Further	studies	
are	 required	 to	 explicitly	 address	 this	 question	 in	 humans	 by	 conducting	muscle	







muscle	 fibre	bundles	 from	 the	 rat	promotes	protein	 accretion	 (Hamdi	&	Mutungi	
2011),	 with	 effects	 mediated	 by	 mitogen-activated	 protein	 kinase	 (MAPK),	 and	





exercising	 DHT	 response	 under	 chronic	 training	 load.	 Depletion	 of	 circulating	



























active	 young	 men,	 particularly	 when	 sprinting	 cadence	 is	 high.	 It	 would	 be	 of	















ketone	 ester	 consumption	 has	 been	 shown	 to	 improve	 endurance	 performance	
during	time	trial	style	exercise	 (Cox	et	al.,2016)	 it	 is	not	currently	known	whether	
nutritional	ketosis	can	benefit	more	intermittent	endurance	performance.	This	study	
aimed	to	determine	the	impact	of	ketone	ester	consumption,	at	the	upper	end	of	the	
recommended	 dosing	 range	 (10mg/min/kg-body-mass)	 on	 repeat	 sprint	 cycling	
performance	 following	 pre-fatigue.	 Fourteen	 well	 trained	 men	 performed	 three	
randomised	trials	of	20-min	steady	state	(SS)	cycling	at	80%	of	20-min	work	capacity	
followed	immediately	by	ten	30s	sprints	with	90s	recovery.	Trials	were	performed	
following	 consumption	 of	 water	 (H20),	 a	 ketone	 ester	 drink	 (KET)	 or	 a	 calorie	
matched	 carbohydrate	 drink	 (CHO).	 Compared	 to	 CHO,	 KET	 resulted	 in	 a	 2.1%	
decrement	 in	 average	 sprint	 power	 (P<0.01)	 and	 attenuated	 exercise	 induced	
increases	 in	 plasma	 lactate	 (P<0.001),	 glucose	 (P<0.001),	 NEFA	 (P<0.001),	
dihydrotestosterone	 (DHT;	 P=0.07)	 and	 testosterone/cortisol	 ratio	 (T/C;	 P=0.07),	
whilst	elevating	plasma	cortisol	(P<0.05).	The	difference	between	KET	and	CHO	in	the	
T/C	ratio	response	to	exercise	correlated	with	the	difference	in	average	sprint	power	





A	 ketone	 ester	 drink	 has	 recently	 been	 developed	 that	 can	 raise	 ketone	 body	
concentration	 in	 the	 body,	 when	 consumed	 as	 part	 of	 a	 normal	 diet,	 to	 those	




increasing	 ketone	 body	 availability	 during	 eucaloric	 exercise	 has	 the	 potential	 to	
profoundly	 alter	 exercise	 metabolism	 (Cox,	 2013;	 Cox	 et	 al.,	 2016)	 and	 initial	
laboratory	performance	trials	indicate	that	nutritional	ketosis	may	confer	ergogenic	
benefit	to	sustained	endurance	performance	of	30-minutes	duration	or	more	(Cox,	
2013)	 and	 to	 mixed	 intensity	 gameplay	 simulation	 of	 90-minutes	 duration	
(unpublished	data).		
	




likely	 failed	 to	 fully	 represent	 the	 workload	 excursions	 more	 typical	 of	 outdoor	
endurance	 sports	 (Sharma	 et	 al.,	 2015)	 where	 large	 fluctuations	 in	 workload	 are	















for	 climactic	 attendance	 to	 motivation	 in	 performance	 assessment.	 This	 view	 is	






to	 sustain	 repeated	sprinting	under	 fatigue,	a	key	performance	 requirement	 for	a	
number	of	outdoor	endurance	sports.	Ketone	ester	will	be	fed	at	the	upper	end	of	
the	 recommended	dosing	 range	 (10mg/kg	body	mass/min	of	exercise)	 to	address	
previous	concerns	 regarding	a	minimal	 threshold	dose	 for	efficacy.	 In	order	 to	go	
some	way	to	addressing	the	issue	of	performance	motivation	in	laboratory	trials,	the	








7.6	 cm;	 body	 mass	 (BM)	 77.5	 ±	 9.3	 kg).	 All	 participants	 completed	 a	 self-report	
training	questionnaire	and	were	categorised	as	‘recreational’	or	‘competitive’	cyclists	
or	 triathletes.	 The	 study	 received	 approval	 from	 the	 University	 of	 Bath	 Research	





This	 study	 followed	 a	 double-blinded,	 randomised	 cross-over	 design.	 Participants	
attended	 the	 laboratory	 on	 six	 occasions	 each	 separated	 by	 7	 days.	 In	 order	 to	
normalize	 for	 circadian	 variation	 in	 hormonal	 state	 (Hayes,	 Bickerstaff,	 &	 Baker,	
2010)	all	 testing	 took	place	at	 the	same	time	of	 the	evening	each	week.	Diet	and	
exercise	were	recorded	for	the	24	hours	before	the	first	trial	and	participants	were	
asked	to	repeat	this	routine	before	all	subsequent	trials.	All	exercise	was	conducted	
on	 air-braked,	 stationary	 cycle	 ergometers	 (Wattbike	 Pro,	 UK)	 under	 controlled	
laboratory	conditions	at	20°C	and	50%	humidity.	Wattbike	manufacturer	reported	












On	 the	 first	 preliminary	 trial	 day	 all	 participants	 performed	 a	 20-minute	maximal	






















For	 the	 three	 main	 trials	 participants	 followed	 the	 same	 trial	 procedure	 as	 the	
familiarisation	 days	 whilst	 also	 being	 randomly	 assigned	 drinks	 containing	 either	




glucose	 and	 fructose	 in	 the	 ratio	 2:1	 (Currell	 &	 Jeukendrup,	 2008).	 	 Drinks	 were	
blinded	by	colour	and	flavour	matching	and	were	also	matched	for	volume	by	the	
addition	 of	 water.	 All	 experimental	 drinks	 were	 consumed	 in	 a	 single	 bolus	 45-





















drawn	 and	 inserted	 into	 EDTA	 collection	 tubes	 (EDTA	 5ml,	 Sarstedt,	Germany)	 at	
baseline,	 prior	 to	 the	 onset	 of	 exercise,	 immediately	 after	 the	 20-minute	 bout	 of	
cycling	and	following	the	4th	and	10th	sprint	efforts.	Blood	was	then	centrifuged	and	
the	 plasma	 fraction	 retained	 (thereby	 rendering	 the	 sample	 acellular).	 Plasma	
samples	were	immediately	transferred	to	polypropylene	Eppendorf	tubes	and	frozen	
at	-80oC	for	later	analysis	of	glucose,	lactate,	glycerol,	free	fatty	acids,	ketone	bodies	
and	 steroid	 hormones.	 Plasma	 metabolites	 (lactate,	 glucose,	 non-esterified	 fatty	
acids	 (NEFA),	 glycerol	 and	 betahydroxybutyrate	 (BHB))	 were	 analysed	 by	
spectrophotometry	using	commercially	available	analysis	kits	(RX	Daytona,	Randox,	













a	 two-way	 (treatment	 x	 time)	 general	 liner	 model	 for	 repeated	 measures	 was	
employed	 for	all	 serial	measures,	with	 the	Greenhouse-Geisser	correction	applied	
























73.8W	with	no	 significant	 difference	between	 the	 first	 and	 second	 familiarisation	
visits.	 Average	 sprint	 power	 during	 the	 CHO	 (518.1	 ±	 72.9W)	 and	 H2O	 (515.8	 ±	












CHO:	 P<0.001),	 glycerol	 (H2O:	 P<0.001;	 KET:	 P<0.001;	 CHO:	 P<0.001)	 and	
testosterone	(H2O:	P<0.01;	KET:	P<0.01;	CHO:	P<0.01)	following	completion	of	ten	
sprints.	In	addition,	during	the	water	and	carbohydrate	trials	plasma	glucose	(H2O:	






































	 Water	(H2O)	 Ketone	Ester	(KET)	 Carbohydrate	(CHO)	
	 baseline	 post	sprints	 baseline	 post	sprints	 baseline	 post	sprints	
Lactate	(mmol/l)	 1.3	±	0.4	 16.4	±	3.0***	 1.3	±	0.6	 15.1	±	2.1***,†	 1.2	±	0.4	 17.0	±	2.1***,‡‡‡	
Glucose	(mmol/l)	 5.0	±	0.7	 6.3	±	1.4**	 4.8	±	0.7	 5.4	±	1.3†††	 4.9	±	0.5	 6.1	±	1.4**,‡‡‡	
NEFA	(mmol/l)	 0.17	±	0.10	 0.27	±	0.20|	 0.13	±	0.09	 0.07	±	0.04**,††	 0.15	±	0.12	 0.11	±	0.08‡‡‡	
Glycerol	(umol/l)	 32.1	±	15.9	 160.3	±	52.3***	 27.9	±	10.3	 136.9	±	60.2***	 31.9	±	11.0	 152.7	±	53.3***	
BHB	(mmol/l)	 0.1	±	0.0	 0.1	±	0.0	 0.1	±	0.0	 2.3	±	0.8***,†††	 0.1	±	0.0	 0.1	±	0.0‡‡‡	
Testosterone	(ng/ml)	 2.79	±	0.91	 3.52	±	1.16**	 2.69	±	0.92	 3.53	±	1.10**	 2.59	±	0.86	 3.46	±	0.93**	
DHT	(pg/ml)	 991.5	±	444.8	 1138.3	±	521.4**	 1005.6	±	496.6	 1080.6	±	585.5	 1096.1	±	520.0	 1175.6	±574.8*,+	
Cortisol	(ng/ml)	 57.7	±	14.5	 63.7	±	23.3	 63.9	±	20.1	 97.4	±	40.7**,††	 60.8	±	17.1	 74.2	±	37.9‡	
Testosterone/Cortisol	 0.050	±	0.018	 0.061	±	0.029	 0.047	±	0.026	 0.048	±	0.040†	 0.046	±	0.018	 0.060	±	0.044+	
	
Table	6.1.	Blood	plasma	metabolite	and	hormonal	responses	at	baseline	and	after	all	ten	sprints	for	






ketone	 ester	 trial	 post	 sprints	 plasma	 lactate	 (P<0.05),	 glucose	 (P<0.001),	 NEFA	
(P<0.01)	and	testosterone/cortisol	ratio	(P<0.05)	were	all	decreased	and	both	BHB	
(P<0.001)	and	cortisol	(P<0.01)	were	increased.	Compared	to	the	carbohydrate	trial,	
in	 the	 ketone	 ester	 trial	 post	 sprints	 plasma	 lactate	 (P<0.001),	 glucose	 (P<0.001),	
NEFA	 (P<0.001),	 dihydrotestosterone	 (P=0.07)	 and	 testosterone/cortisol	 ratio	





Perceived	affect	declined	significantly	 from	baseline	 in	all	 trials	with	a	 trend	 for	a	
greater	 fall	 in	 the	 ketone	 ester	 trial	 that	 did	 not	 reach	 significance.	 RPE	 rose	
110	
	
significantly	 in	 all	 trials	 from	 ‘fairly	 hard’	 levels	 after	 steady	 state	 cycling	 to	 near	
maximal	values	after	ten	sprints	(H2O:	P<0.001;	KET:	P<0.001;	CHO:	P<0.001).	There	
was	a	small	but	significant	difference	between	the	water	and	carbohydrate	trials	for	









Baseline	 2.7	±	1.4	 2.6	±	1.6	 2.7	±	1.5	
PreSS	 2.8	±	1.4	 2.3	±	1.6	 2.6	±	1.5	
PostSS	 1.3	±	1.6**	 0.9	±	1.5**	 1.4	±	1.7*	
PostSp4	 0.1	±	2.0***	 -1.2	±	1.6***	 -0.4	±	1.7***	
PostSp10	 -2.3	±	1.8***	 -2.9	±	1.5***	 -2.4	±	1.8***	
RPE	
PostSS	 13.1	±	2.3	 12.9	±	1.9	 12.7	±	2.0	
PostSp4	 15.6	±	1.7***	 16.6	±	1.6***	 16.2	±	1.6***	























Baseline	 0.3	±	0.8	 0.2	±	0.4	 0.2	±	0.6	
Exercise	 3.0	±	3.5**	 8.3	±	8.5**,†	 3.6	±	4.8*,‡	
Upper		
GI	Sum	 Exercise	 0.5	±	1.3	 4.9	±	5.2
††	 1.5	±	2.2‡	
Lower		
GI	Sum	 Exercise	 0.1	±	0.3	 1.1	±	2.7	 0.2	±	0.6	
Systemic	

































































































































































note	of	 caution	 regarding	 the	utility	 of	 nutritional	 ketosis	 for	 sport	 performances	
requiring	sustained	sprint	effort	with	 limited	recovery	between	sprints.	This	result	
sits	 in	 contrast	 to	 recent	 findings	 regarding	 the	 potential	 ergogenic	 utility	 of	
nutritional	ketosis	 for	 longer	duration	exercise	performance	(Cox	et	al.,	2016)	and	
points	to	a	potential	threshold	duration	and/or	intensity	of	effort,	that	has	yet	to	be	










ketone	 ester	 (Cox	 et	 al.,	 2016)	 this	 ketotic	 milieu	 resulted	 in	 the	 suppression	 of	
exercise	induced	elevations	in	circulating	lactate,	glucose	and	free	fatty	acids	(NEFA).	
Such	 changes	would	 indicate	 that	 the	 presence	 of	 significant	 levels	 of	 circulating	
ketone	bodies	during	exercise	altered	either	or	both	of	the	mobilisation	and	oxidative	
fate	of	both	glycolytic	and	lipolytic	substrate.	Whilst	fuel	selection	appears	a	likely	
candidate	 for	 underpinning	 the	 ergogenic	 potential	 of	 nutritional	 ketosis	 during	
longer	duration	exercise	(Cox	&	Clarke,	2014,	Cox	et	al.,	2016),	in	the	present	study	
















Compared	 between	 trials,	 the	 change	 in	 T/C	 ratio	 with	 exercise	 correlated	
significantly	 with	 the	 change	 in	 sprint	 performance	 indicating	 that	 the	 shifting	
dynamics	 of	 HPA	 axis	 activity	 during	 exercise	 were	 predictive	 of	 performance	
outcome.	The	HPA	axis	is	a	ubiquitous	signalling	system	with	an	array	of	modulating	
inputs	and	wide	ranging	output	effects	during	exercise	(Crewther	et	al.,	2011),	which	






drink.	 Ketone	 ester	 feeding	 resulted	 in	 significantly	 greater	 GI	 symptoms,	 with	
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increases	 in	upper	GI	symptoms	 in	particular,	and	a	non-significant	 trend	towards	
worsening	 affect	 during	 exercise	 that	 may	 have	 contributed	 to	 performance	
impairment,	perhaps	 in	part	 through	 the	 influence	of	HPA	axis	 signalling	 (Cook	&	
Crewther,	2012a).	
	
The	participants	 in	 this	 study	were	all	 regular	 cyclists	with	a	prolonged	history	of	
moderate	 level	 cycle	 training	 and	 varying	 levels	 of	 engagement	 in	 competitive	
cycling.	However,	it	is	clear	from	their	training	history	and	performance	capacity	that	














may	have	been	minimised	 in	 comparison	 to	 single-participant	 study	methods	but	








Nutritional	 ketosis	 impaired	 repeat	 sprint	 cycling	 performance	 following	 pre-
fatiguing	 exercise	 in	 a	 competitive	 group	 dynamic.	 Performance	 impairment	with	
ketosis	may	have	resulted	from	either	or	a	combination	of	 impaired	peak	exercise	


















in	 depth	 for	 a	 single	 sport.	 Ninety-one	 athletes	 across	 eight	 sports	 consumed	 a	




symptoms.	 GI	 symptoms	 were	 more	 prevalent	 during	 training	 and	 competition	



















Recently,	 an	 edible	 source	 of	 ketosis,	 in	 the	 form	 of	 a	 ketone	 ester,	 has	 been	
developed	in	an	attempt	to	provide	an	alternative	to	ketogenic	diets	for	Parkinson’s	
disease	and	epilepsy	(Kashiwaya	et	al.,	2010).	It	is	now	possible	to	raise	circulating	
ketone	 body	 concentration,	 with	 no	 acid	 load,	 in	 a	 dose	 dependent	 fashion	 by	
providing	ketone	esters	in	a	drink,	which	can	be	consumed	as	part	of	a	normal	diet.	














The	practice	of	 inferring	 the	real	world	value	of	 interventions	aimed	at	 improving	
sports	performance,	such	as	nutritional	supplementation,	by	examining	their	impact	
on	 laboratory	 performance	 measures	 or	 physiological	 surrogates,	 has	 attracted	
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strong	critique	 (Atkinson	&	Nevill,	 2001).	Whilst	 surrogate	performance	measures	
observed	 in	 highly	 controlled	 settings	 improve	 internal	 validity	 and	 increase	 the	
likelihood	of	a	clear	outcome,	their	translation	to	the	externally	valid	world	of	elite	
sports	performance	 is	often	questionable,	particularly	where	a	 less	highly	 trained	
population	has	been	studied	in	an	area	where	training	status	is	likely	to	be	a	factor	
in	the	measured	response.	The	difficulties	inherent	in	gaining	meaningful	access	to	
elite	 athletes	 has	 led	 some	 researchers	 to	 suggest	 that	 a	more	 valid	 approach	 to	









&	 Aughey,	 2010;	 MacLeod,	 Morris,	 Nevill,	 &	 Sunderland,	 2009;	 Portas,	 Harley,	
Barnes,	&	Rush,	2010).	Furthermore,	this	technology	is	considered	to	be	sufficiently	
valid	 and	 reliable	 to	 detect	 altered	 running	 across	 a	 match,	 between	 matches,	
between	levels	of	competition,	and	between	types	of	matches	(Aughey,	2011).		
	


























age	 25.1	 ±	 5.7	 yr,	 height	 169.1	 ±	 6.8	 cm,	 body	 mass	 (BM)	 59.7	 ±	 7.5	 kg).	 All	












of	 both	 individual	 and	 team	 sports	 identified	 as	 having	 potential	 to	 benefit	 from	
nutritional	 ketosis.	 For	 each	 sporting	 case	 study,	 athletes	 were	 supported,	 in	
collaboration	with	appropriately	trained	personnel	in	each	sport,	through	a	process	










All	 ketone	 ester	 drinks	 were	 formulated,	 produced	 and	 secured	 in	 tamper	 proof	













training	 to	 familiarise	 participants	 to	 the	 ketone	 ester	 drink,	 assess	 individual	
tolerability	 and	 refine	 the	 dosing	 regimen	 to	 ensure	 the	 delivery	 of	 a	 sustained	
moderate	 ketosis	 during	 sporting	 performance.	 The	 development	 of	 optimal	
individual	dosing	always	began	with	the	ingestion	of	ketone	ester	at	8	mg/kg	body	
mass/min	of	exercise,	the	dose	shown	to	be	most	effective	in	previous	trials	for	the	







exercise,	 during	 exercise	 and	 post-exercise	 for	 the	 analysis	 of	 blood	 ketone	
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ketone	 ester	 during	 training	 and	 competition	 performances.	 Participants	 were	
required	 to	 record	 subjective	 ratings	 of	 drink	 palatability	 and	 gastro-intestinal	
tolerance	during	all	 trials	 and	encouraged	where	possible	 to	 record	blood	ketone	
concentration	 across	 the	 intervention	 period.	 Each	 case	 study	 sport	 was	 also	
encouraged	 to	 capture	 performance	 analysis	 data	 relating	 to	 interventional	
performances	alongside	any	relevant	co-factors	for	that	sport	(e.g.	home	advantage;	






Data	 from	 each	 sporting	 case	 study	was	 characterised	 using	 descriptive	 statistics	
alongside	 overall	 responses	 across	 the	 case	 study	 series	 for	 comparison.	 Where	
appropriate,	 group	 differences	 were	 compared	 by	 one-way	 analysis	 of	 variance	















		 A	 B	 C	 D	 E	 F	 G	 H	 Overall	
Participants	 3	 4	 10	 1	 14	 55	 2	 2	 91	
Total	Usages	 14	 6	 24	 5	 52	 257	 3	 13	 374	
Ave	Usage/Participant	 4.7	 1.5	 2.4	 5.0	 3.7	 4.7	 1.5	 6.5	 4.1	
	 	 	 	 	 	 	 	 	 	
Usage	at	rest	 	 	 9	 	 12	 	 	 	 21	
Usage	in	training	 10	 6	 13	 2	 31	 147	 3	 6	 218	
Usage	in	competition	 4	 	 2	 3	 9	 110	 	 7	 135	
	 	 	 	 	 	 	 	 	 	
Blood	Ketone	(mmol/l)	 1.5	±	0.4	 1.4	±	0.4	 1.9	±	1.0	 2.0	±	0.5	 2.5	±	1.2	 1.5	±	0.7	 1.4	±	0.7	 1.8	±	1.0	 1.8	±	0.5	






The	 presence	 of	 gastro-intestinal	 (GI)	 symptoms	 (Table	 7.2;	 Figure	 7.1)	 was	 high	
across	 all	 trials	 with	 40%	 of	 participants	 describing	 mild	 GI	 symptoms	 and	 41%	
describing	 moderate	 GI	 symptoms.	 Whilst	 considerable	 variation	 in	 symptom	
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occurrence	 existed	 between	 case	 study	 sports,	 for	 participants	 who	 conducted	
resting	 trials	 there	was	 a	 significant	 increase	 in	mild	 and	moderate	GI	 symptoms	
during	training	and	competition	compared	to	trials	at	rest	(P<0.01).	
	
		 A	 B	 C	 D	 E	 F	 G	 H	 Overall	
All	Sessions	 	 	 	 	 	 	 	 	 	
%	no	GI	symptoms	 20%	 50%	 46%	 100%	 50%	 11%	 33%	 20%	 19%	
%	mild	GI	symptoms	 30%	 33%	 29%	 0%	 36%	 42%	 67%	 40%	 40%	
%	moderate	GI	symptoms	 50%	 17%	 25%	 0%	 14%	 47%	 0%	 40%	 41%	
	 	 	 	 	 	 	 	 	 	
Resting	Trials	 	 	 	 	 	 	 	 	 	
%	no	GI	symptoms	 	 	 67%	 	 100%	 	 	 	 80%	
%	mild	GI	symptoms	 	 	 33%	 	 0%	 	 	 	 20%	
%	moderate	GI	symptoms	 	 	 0%	 	 0%	 	 	 	 0%	
	 	 	 	 	 	 	 	 	 	
Training	Trials	 	 	 	 	 	 	 	 	 	
%	no	GI	symptoms	 13%	 50%	 38%	 100%	 29%	 13%	 33%	 16%	 16%	
%	mild	GI	symptoms	 25%	 33%	 31%	 0%	 50%	 39%	 67%	 38%	 38%	
%	moderate	GI	symptoms	 63%	 17%	 31%	 0%	 21%	 48%	 0%	 46%	 46%	
	 	 	 	 	 	 	 	 	 	
Competition	Trials	 	 	 	 	 	 	 	 	 	
%	no	GI	symptoms	 50%	 	 0%	 100%	 44%	 12%	 	 43%	 14%	
%	mild	GI	symptoms	 50%	 	 0%	 0%	 56%	 41%	 	 0%	 41%	


























and	 topped	up	again	at	half-time	according	 to	dosing	 regimens	developed	during	





All	 case	 study	 participants	 followed	 the	 guidelines	 in	 Methods	 A	 to	 become	
familiarised	 with	 the	 experimental	 drinks	 and	 develop	 optimal	 dosing	 regimens.	
Participants	were	instructed	to	record	their	food	and	fluid	intake	for	24	hours	before	












unit	 was	 immediately	 downloaded	 to	 a	 laptop	 computer	 and	 analysed	 using	













for	 volume,	 with	 the	 support	 of	 an	 independent	 food	 technology	 specialist	 (IFN,	
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Participants	 rated	 the	 palatability	 of	 the	 both	 trial	 drinks	 based	 on	 a	 drink	
pleasantness	scale	 (General	Methods:	Appendix	4)	directly	after	consumption	and	




during	 exercise	 and	 post-exercise	 for	 the	 analysis	 of	 blood	 ketone	 concentration	





Following	 the	 cross-over	 trial	 some	 participants	 chose	 to	 continue	 experimenting	
with	the	ketone	ester	drink	in	two	subsequent	tournaments	and	a	prior	tournament	










a	 two-way	 (treatment	 x	 time)	 general	 liner	 model	 for	 repeated	 measures	 was	
employed	 for	all	 serial	measures,	with	 the	Greenhouse-Geisser	correction	applied	
























Half-time End Baseline Pre-warm	
up





















Gastro-intestinal	 symptom	 prevalence	 was	 high	 during	 training	 and	 competition	
following	both	ketone	ester	and	carbohydrate	consumption	(Figure	7.3).	There	were	
no	 significant	 differences	 between	 treatments	 for	 mild	 symptom	 prevalence.	































































































































































































































































Ketone	Ester	 3347.3	±	560.0	 1076.9		±	231.7	 6200.7	±	802.5	
Carbohydrate	 3345.2	±	581.1	 1117.4	±	224.3	 6051.9	±	889.2	
	 	 	 	 	
Opposition	matches	(n=7)	
Ketone	Ester	 3225.1	±	479.6*	 1077.9	±	264.6	 5998.1	±	753.1+	
Carbohydrate	 3533.4	±	540.0	 1129.4	±	288.5	 6340.1	±	910.6	
	
Table	7.3.	low	speed	run,	high	speed	run	and	total	distance	covered	following	consumption	of	ketone	













without	KET with	CHO with	KET without	KET with	KET without	KET with	KET















































































































Nutritional	 strategies	 for	 sport	 have	 long	 been	 known	 to	 offer	 somewhat	 of	 a	
poisoned	chalice	where	perhaps	fortune	favours	the	brave.	It	is	well	established	that	









in	a	previous	 laboratory	 trial	of	ketone	ester	usage	 for	 repeat	sprint	performance	
(Chapter	6)	 suggesting	 that	at	 least	 for	 some	athletes	 in	some	contexts	 it	may	be	
foolhardy	to	bravely	plough	on	through	and	tolerate	worsening	GI	symptoms.	
	
The	 optimal	 dosing	 of	 ketone	 esters	 for	 sports	 performance	 remains	 to	 be	
established	in	the	majority	of	situations.	Given	the	symptom	profile	described	here	
alongside	relatively	low	levels	of	ketosis	relative	to	recent	laboratory	guidelines	(Cox	









of	 adoption	 of	 nutritional	 ketosis	 as	 a	 strategy	 for	 improvement	 of	 sports	
performance.	Once	the	case	study	had	progressed	to	the	point	where	ketone	ester	
adopters	 had	 continued	 by	 choice,	 which	 involved	 those	 with	 greater	 perceived	
tolerance	issues	self-selecting	out,	there	was	evidence	of	performance	benefit	with	
an	 increase	 in	 sustained	 high	 intensity	 running	 under	 the	 most	 demanding	 of	
competition	 settings	 (Figure	7.5).	However,	earlier	 in	 the	 study	when	participants	
were	 subject	 to	 the	 rigours	 of	 a	 blinded,	 randomised	 trial,	 ketone	 ester	 usage	
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appeared	 to	 reduce	 lower	 intensity	 run	distances	 (Table	7.3),	perhaps	signalling	a	
demotivating	influence	of	the	symptom	profile.	
Run	distances	 in	gameplay	 team	sports	do	not	 confer	ubiquitous	advantage	 in	all	
competitive	contexts	(Aughey,	2011).	It	is	possible	that,	against	a	lower	standard	of	
opponent	 in	 Tournament	 2	 or	 simply	 a	 different	 kind	 of	 tactical	 challenge,	
participants	simply	employed	adaptive	strategies	to	win	the	game	in	ways	other	than	
utilising	 physical	 advantage	 by	 running	 faster	 and	 further	 than	 their	 opponents.	
Whether	 such	 advantages	 can	 be	 garnered	 when	 the	 opponent	 is	 of	 a	 higher	
capability	is	both	unknown	in	the	current	context	and	a	major	confounding	factor	in	
general	 for	 attempts	 to	 assess	 the	 efficacy	 of	 discreet	 interventions	 during	 team	
sports	performance.	That	significant	differences	were	seen	in	run	performance	from	





Consumption	 of	 ketone	 ester	 drinks	 during	 real	 world	 sports	 training	 and	
performance	 resulted	 in	moderate	nutritional	 ketosis.	Drinking	 ketone	esters	was	
generally	 considered	 unpleasant	 and	 resulted	 in	 a	 significant	 degree	 of	 gastric	
discomfort	for	the	majority	of	athletes.	The	performance	impact	of	nutritional	ketosis	
was	unclear	with	only	limited	evidence	for	benefit	in	high	speed	distance	run	during	
team	 sport	 where	 athletes	 had	 self-selected	 their	 participation	 based	 on	 prior	
experience	with	the	consumption	of	the	ketone	ester.	Whether	nutritional	ketosis	













linked	 with	 the	 competing	 demands	 of	 exploration	 and	 survival.	 The	 growing	
speculation,	 increasingly	 supported	 now	 by	 emerging	 archaeological	 and	 genetic	
evidence	(Ingman,	Kaessmann,	Pääbo,	&	Gyllensten,	2000;	White	et	al.,	2003),	that	
all	 modern	 humans	 can	 trace	 their	 lineage	 back	 to	 Africa,	 is	 testament	 to	 the	
enduring	spirit	of	adventure	which	sits	deep	within	us.	It	is	this	adventurous	impulse	
which	 has	 driven	 us	 to	 scale	 improbable	 peaks,	 has	 fed	 our	 insatiable	 thirst	 for	



























mouse	 to	 exploit	 the	 memory	 of	 historical	 experience	 in	 the	 regulation	 of	 goal	
oriented	behaviour	 (Dvorkin,	Benjamini,	&	Golani,	2008),	 the	view	that	existential	
awareness	may	be	a	uniquely	human	condition	pervades	despite	significant	attempts	
to	 identify	 a	 level	 of	 cognition	 in	 non-human	 primates	 suggestive	 of	 a	 systemic	
disposition	 to	 perceive	 beliefs	 and	 desires	 as	 master	 regulators	 of	 behavioural	
schema	 (Call	 &	 Tomasello,	 2008).	 Nonetheless	 the	 core	 biological	 response	 to	







Sapolsky,	 2004).	 By	 way	 of	 example	 there	 is	 growing	 evidence	 that	 psychosocial	
stress	 can	moderate	 the	drive	 to	eat	and	 the	 selection	of	more	palatable,	energy	
dense	 food	 choices	 (Groesz	 et	 al.,	 2012).	 Such	 adaptations	may	 have	 served	 the	
needs	of	our	evolutionary	forebears	well	when	resources	were	scarce	but	have	clear	











by	 demonstrating	 that	 this	 stock	 of	 ‘adaptation	 energy’,	whilst	 limiting	 in	 a	 dose	











that	 the	 relationship	 between	 stress	 and	 function	 may	 be	 best	 modelled	 by	 an	















1937).	 The	 identification	 of	 extensive	 cross-talk	 between	 neural,	 immune	 and	
endocrine	 structures	 in	 the	 years	 that	 followed	 has	 further	 solidified	 the	 role	 of	
endocrine	 signals	 as	 functional	 regulators	 of	 resource	 deployment	 that	 are	
dynamically	responsive	to	both	mental	and	physical	state	and	temporally	responsive	
to	historical	experience.	This	 is	perhaps	best	exemplified	by	the	cascade	of	events	










(R.	 M.	 Sapolsky,	 Krey,	 &	 McEwen,	 1986),	 the	 many	 roles	 of	 the	 glucocorticoid	
signalling	system	in	mobilising	systemic	resources	and	regulating	behaviour	in	order	
to	manage	risk	in	the	face	of	stressful	stimuli.	This	extensive	review	established	that	
acute	 upregulation	 of	 GC	 signalling	 is	 an	 essential	 component	 of	 the	 functional	
response	to	stress,	with	failures	of	the	stress	response	occurring	as	a	result	of	either	
an	 inability	 to	 activate	 glucocorticoid	 secretion	 in	 response	 to	 a	 stressor	 or	 an	








and	 sustain	 stress	 resilience	 (R	 M	 Sapolsky,	 1986).	 Further,	 it	 appears	 that	 this	
cerebral	 energetic	 compromise	 may	 be	 compounded	 by	 a	 GC	 cascade	 driven	
inhibition	of	uptake	and	utilisation	of	glucose	since	ketone	ester	feeding	was	more	
effective	 than	 glucose	 feeding	 in	 protecting	 against	 neuronal	 damage.	 The	
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behavioural	 corollary	of	 this	energetic	 cascade	 lies	most	pointedly	 in	 the	 sickness	










and	 response	 pathways.	 Within	 the	 stress-adaptation	 cycle	 we	 therefore	 have	 a	
significant	 degree	 of	 feed-forward	 and	 feed-back	 cross	 talk	 creating	 a	 web	 of	
adaptation.	
	











of	 Physiological	 Sciences	 (IUPS)	 was	 one	 of	 concern	 for	 the	 future	 of	 systems	
physiology.	In	‘The	Logic	of	Life’,	a	collection	of	essays	that	accompanied	the	congress	
programme,	the	tone	was	one	of	battle	readiness	(Noble	&	Boyd,	1993).	That	the	




(Hunter,	 Smith,	 Fernandez,	 &	 Tawhai,	 2005).	 In	 expanding	 upon	 this	 view	 of	
intelligent,	 integrated	 functional	 systems,	 future	 physiological	 research	 would	 do	
well	 to	 consider	 that	 the	 brain	 appears,	 through	 the	 collation	 of	 historical	
experiences,	 situational	 stressors	 and	 relative	 risk,	 to	 manage	 the	 dynamics	 of	
functional	adaptation	in	much	the	same	way	as	it	manages	the	delivery	of	a	single	






examining	 the	 adaptive	 characteristics	 of	 stress	 exposure.	 When	 examining	
adaptation	 to	 exercise	 training	 and	 sports	 performance	 from	 the	 perspective	 of	
dynamic	functional	systems	(Phillips	et	al.,	2010)	it	therefore	becomes	necessary	to	
give	 due	 consideration	 to	 such	 factors	 as	 the	 training	 history	 of	 experimental	




and	 the	 resources	 requiring	 to	 be	 mobilised	 in	 order	 to	 achieve	 it.	 That	 such	
information	 is	 seldom	 reported	 in	 the	 literature	 on	 exercise	 training	 and	 sports	
performance	 is	perhaps	 indicative	of	 the	extent	 to	which	 the	debate	has	become	
wedded	to	reductionary	thought.	
	
It	 is	 becoming	 increasingly	 popular	 to	 examine	 the	 acute	 cellular	 environment	
following	 a	 single	 exercise	 stimulus,	with	 an	 ever	more	 sophisticated	microscope	
being	applied	to	the	transient	perturbations	evident	 in	Bernard’s	 ‘milieu	 intérieur’	
(Holmes,	1986).	At	this	juncture,	Bernard	himself	has	sent	forward	some	prophetic	






The	 work	 reported	 here	 aimed	 to	 take	 a	 holistic	 view	 of	 the	 utility	 of	 a	 novel	










of	 substrate	 supply	 and	 energetics	 is	 not	 even	 half	 of	 the	 picture	 given	 the	
psychodynamics	 at	 play	 when	 an	 athlete	 chooses	 to	 adopt	 a	 nutritional	
interventional	in	the	cauldron	of	the	sporting	arena.	
	
The	 findings	presented	here	sound	a	 largely	cautionary	note	and	go	some	way	 to	
describing	the	bounds	of	efficacy	for	utility	of	the	ketone	ester	drink.	That	nutritional	
ketosis	can	significantly	alter	exercising	substrate	selection	and	energetics	and	in	so	
doing	 may	 confer	 a	 small	 but	 significant	 positive	 impact	 on	 endurance	 exercise	







be	 translated	 well	 beyond	 their	 limits	 and	 used	 to	 promote	 commercial	 and	
competitive	 interests	 without	 full	 consideration	 of	 the	 ecological	 validity	 of	 the	






optimal	 dosing	 within	 tolerable	 constraints	 (Chapters	 4,	 6	 &	 7),	 the	 modes	 and	
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contexts	 of	 exercise	 helped	 by	 nutritional	 ketosis	 and	 perhaps	more	 importantly	
those	with	potential	to	be	harmed	(Chapters	4,	6	&	7)	and	the	psycho-physiological	
dynamics	 modulating	 the	 behavioural	 response	 to	 ketotic	 exercise	 performance	
(Chapters	5	&	6).	
	




Figure	 7.2)	 and	 that,	 for	 some,	 this	 may	 have	 resulted	 in	 performance	 benefit	
(Chapter	7:	Figure	7.5A)	is	of	great	significance.	However,	this	must	be	tempered	with	
equivocal	evidence	for	wider	performance	impact	(Chapter	7:	Table	7.3)	alongside	
the	 realisation	 that	 gastro-intestinal	 symptoms	 were	 highly	 prevalent	 in	 the	
competitive	arena	(Chapter	7:	Figure	7.3)	and	for	a	large	number	of	athletes	(31%)	







known	 whether	 symptom	 prevalence	 may	 be	 altered	 by	 alternate	 vehicles	 for	
nutritional	ketosis.	Whilst	it	appears	likely	that	ketone	salts	(Plecko	et	al.,	2002)	and	













aggravated	 symptom	 profile	 seen	 for	 ketone	 ester	 usage	 in	 the	 field	 (Chapter	 7:	
Figure	7.3)	it	would	appear	that	there	may	be	a	narrow	window	of	efficacy	regarding	
optimal	ketone	ester	dosing	for	sports	performance.	GI	symptoms	were	significantly	
elevated	 following	 the	 higher	 dose	 of	 ketone	 ester	 (10mg/min/kg-body-mass)	
employed	in	the	repeat	sprint	cycling	trial	reported	here	(Chapter	6:	Table	6.3).	The	





ester	 consumption	on	 repeat	 sprint	 cycling	performance	 following	 a	pre-fatiguing	
bout	of	exercise	(Chapter	6:	Figure	6.1).	This	clearly	defines	not	only	the	bounds	of	
efficacy	of	nutritional	ketosis	but	highlights	the	fact	that	in	the	absence	of	ergogenic	




that	 the	 very	 metabolic	 effects	 that	 may	 confer	 benefit	 during	 more	 sustained	
endurance	exercise	(Cox	et	al.,	2016)	may	cause	harm	during	more	intensive	levels	
of	 demand.	 In	 particular,	 the	 intramuscular	 suppression	 of	 glycolysis	 and	
enhancement	of	lipolysis	seen	by	Cox	et	al.	following	ketone	ester	consumption	was	





Performance	 impairment	 occurred	 in	 a	 task	 requiring	 the	 maintenance	 of	
intermittent	sprinting	which	accumulated	five	minutes	of	high	intensity	effort	within	





Another	key	 finding	 reported	here	was	 the	 relationship	between	 the	dynamics	of	
HPA	axis	activity	and	the	performance	outcome	of	the	repeat	sprint	trial	(Chapter	6:	
Figure	 6.2).	 Emerging	 awareness	 of	 the	 role	 of	 androgenic	 and	 glucocorticoid	
signalling	 in	 the	 regulation	of	 competitive	behaviour	 represents	 a	new	 frontier	 in	
behavioural	 biology	 (McEwen,	 2013)	 that	 could	 go	 some	way	 to	bridging	 the	 gap	
between	holistic	and	mechanistic	approaches	to	understanding	the	dynamics	of	the	







That	 a	 modest	 correlation	 was	 found	 here	 between	 performance	 outcome	 and	
testosterone/cortisol	 ratio	 signalling	 is	 not	 in	 and	 of	 itself	 of	 particular	 note.		
However,	 that	 this	 relationship	 emerged	 against	 the	 backdrop	 of	 a	 competitive	
motivational	climate	(Corbett	et	al.,	2012b)	which	encouraged	both	performance	and	
mastery	 goals	 (Pensgaard	 &	 Roberts,	 2000)	 goes	 some	 small	 way	 towards	








deeper	 subtleties	 at	 play.	Whilst	 it	will	 never	 be	 possible	 to	 research	 all	 possible	









and	 untrained	 participants,	 and	 towards	 a	 more	 nuanced	 understanding	 of	
participant	 characteristics	 would	 be	 welcome.	 Efforts	 in	 this	 direction	 should	
consider	 more	 fully	 the	 training	 and	 performance	 history	 of	 experimental	
participants	as	well	as	their	motivational	orientation	in	relation	to	the	task	at	hand.	
















profoundly	 challenges	 our	 historical	 views	 on	 substrate	 selection	 and	 energetics.	
However,	care	should	be	taken	not	to	rush	to	broad	brush	conclusions	regarding	the	















































































































































































































































































































































































































































































































































































































































more	 highly	 trained,	 please	 fill	 out	 questions	 for	 both	 your	 current	 and	 former	
athletic	status.	
	 CURRENT	 FORMER	






















How	 many	 times	 do	 you/did	 you	
exercise	per	week?	
...	 ...	




































































How	often	 do	 you/did	 you	 train	 per	
week?	
...	 ...	
How	 long	 does/did	 one	 training	
session	last?	
	 	 	 	 	 	(minutes)	 	 	 	 	 	 	(minutes)	
What	 is	 your	 typical	 training	 load	 in	
hours	or	km’s	per	week?	
	 	 	 	 	 	(km/week)	
	 	 	 	 	 	(hrs/week)	
	 	 	 	 	 	(km/week)	
	 	 	 	 	 	(hrs/week)	





































	 	 	 	 	 	
When	 did	 you	 start	 training	
regularly	for	cycling?	
	 	 	 	 	 	(Year)	








If	 so,	 what	 kind	 of	 races	 do	





























	 	 	 	 	 	
Do	 you	 currently/did	 you	


















	 	 	 	 	 	
☐No	
If	 you	 have	 raced	 in	 the	 last	 5	
years	 what	 is	 your	 best	
competitive	result?	
....	
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Appendix	6	
Exit	Questionnaire	
1.	On	which	of	the	two	trials	do	you	think	you	were	given	the	experimental	drink?	
A.	Trial	1	
B.	Trial	2	
	
2.	Did	you	think	your	time	trial	performance	was	different	between	the	two	trials?	
A.	Trial	1	was	a	lot	better	
B.	Trial	1	was	a	little	better	
C.	Both	trials	were	about	the	same	
D.	Trial	2	was	a	little	better	
E.	Trial	2	was	a	lot	better	
	
